NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
David McKenna Jr
University of Minnesota Twin Cities - Minneapolis / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4679299
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
David McKenna Jr's MOST POPULAR ARTICLES
1-)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer Blood 105 (8), 3051-3057, 2005
2-)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics Blood, The Journal of the American Society of Hematology 117 (3), 1061-1070, 2011
3-)
Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs Nature communications 6 (1), 8472, 2015
4-)
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial The Lancet Respiratory Medicine 3 (1), 24-32, 2015
5-)
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial The Lancet Respiratory Medicine 7 (2), 154-162, 2019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept